The following European companies are joining us for InnoHEALTH 2017 through our association with CBHealthAccess project. The project is a joint cooperation venture of existing e-health and life-science clusters from the Central Baltic region: Tallinn Science Park Tehnopol and Tartu Biotechnology ParkÂ from Estonia, Turku Science Park from Finland, Swedish Medtech from Sweden and Enixus Baltics from Latvia who create a cross-border meta-cluster to solve common challenges of supporting expansion of their innovative companies. These health technology companies are focussed to enter India with their products.
ApiRaysÂ® is a group of passionate researchers, academicians, business developers and legal attorneys that strive to develop efficient biotechnical solutions for cost-effective diagnostics. We are located in the renowned Karolinska Instititutet campus located in beautiful Stockholm.
ApiRaysÂ® has proudly developed a new recombinant apyrase called ApiOneÂ®. ApiOne has been tested for its rapid hydrolyzation and complete elimination of ATP, ATP-analogues, and ATP by-products. This characteristic feature of ApiOne, to degrade ATP in less than a few minutes, makes it superior compared to other similar enzymes available in the market. ApiOne Test Kit (the end-user) product will be offered for several applications (e.g. drug development, water analysis, food & beverage analysis).
For more information, please visit: http://www.apirays.com/
DocuMental Limited is a company involving multisectoral experts and developing digital solutions for mental health and was established in November 2016. The first development was started in May 2016 after successful competition in the EIT Health Accelerator Programmes. The first prototype, DocuMental, was funded by EIT Health and developed by Estonian IT teams. In September 2016 the prototype was piloted and evaluated by an international network. DocuMental was selected by EIT-Health as one of 21 finalists of Business Plan Aggregator 2016 among digital health innovations and it was the only finalist in the mental health sector. As a result, DocuMental Ltd was registered and further product development continues in collaboration with national and international partners. To date, the company has received funding from EIT Health, the North Estonia Medical Centre, Estonian Connected Health and the Estonian Genome Centre. The company is connected to an international network involving top-level experts and specialists in mental health from geographically diverse centers. In addition to the mentioned organisations, the company partners are Imperial College Health Partners and ScanBalt. The company team consists of three chief officers and an advisory board. DocuMental Founder and CEO is professor Eduard Maron.
For more information, please visit: http://www.documental.ee
EMPE Diagnostics AB, an interdisciplinary R&D-based SME focusing to develop multiplex point-of-care diagnostic solutions that can provide reliable clinical information already during the first contact point between the doctor and the patient. EMPE develops proficient and rapid diagnostic solutions for infectious diseases with a special focus on drug-resistance genotypes in Mycobacterium tuberculosis complex and sexually transmitted agents.
EMPEâ€™s indigenous, customised test kits that can provide YES/NO answer in 60 min by developing visual signals and provides reliable clinical information already during the first contact point between the doctor and the patient. Our affordable tests are designed to operate even in resource-limited clinical laboratories, including medical camps.
For more information, please visit:Â http://www.empediagnostics.com/
FibroTx LLC develops and markets non-invasive molecular diagnostic (MDx) tests for applications in clinical dermatology and skin care. FibroTx tests allow biomarker measurements straight from the topical side of skin, with an unparalleled ease-of-use for persons performing the test, and with no burden to persons tested.
FibroTx was founded in November 2005. FibroTx is housed in state-of-the-art laboratory and prototype-manufacturing facilities at the Tallinn Science Park Tehnopol, Estonia.
FibroTx develops, manufactures and markets non-invasive skin diagnostic devices based on proprietary technologies (patents pending):
Transdermal Analysis Patch (TAP): A highly versatile research and development tool for multiplex analyses of protein-based biomarkers on skin. TAP is being offered to customers as a fee-for- service skin diagnostic tool.
Skin Exploratory Lateral Flow (SELF): A skin diagnostic device for multiplex analyses of biomarkers from skin for specialists and home use.
FibroTx is an ISO 9001 certified company since 2008.
For more information, please visit: http://www.fibrotx.com/
Icare Finland Oy is an advanced health technology company based in Vantaa, Finland. Company is a part of Revenio Group Corporation, a public company listed on the Helsinki Stock Exchange.
IcareÂ® product line consists of tonometers – specialized instruments for measuring, monitoring and screening of Intra Ocular Pressure (IOP) as a part of diagnosing Glaucoma. Ease of use and operational reliability are cornerstones of the Icare product family’s success. The unique, patented rebound technology is based on the measuring principle, in which a light-weight probe makes a momentary contact with the cornea. The patient-friendly Icare tonometers require no anesthetic drops or specialized skills for use. Eye disease are traditionally examined by specialists. As patient-oriented screenings are becoming more common, tonometers are increasingly becoming tools for general practitioners, opticians, optometrists and first-aid staff.
Today the Icare tonometers have obtained worldwide official clearances (CE, US FDA, CFDA etc.) and tens of thousands of satisfied users in over 70 countries.
For more information, please visit:Â http://www.icaretonometer.com
Predicare AB was established in 2010. It provides a Medical Emergency Decision Support System called RETTSÂ© Rapid emergency triage and treatment system. Their system covers 95% of Swedish and 60% of Norwegian Emergency rooms and Ambulances. The system enables more efficient medical staff utilization with lesser variation between observers and make faster and safer decisions. The triage system is built through co-creation with Emergency Medicine doctors worldwide and is cutting edge.
For more information, please visit: http://predicare.eu/
Renapharma, with a mission of combining scientific dialogue, knowledge and innovative technology in healthcare is providing innovative and quality products in the pharmaceutical, health food and medical technology. It is a family owned pharmaceutical company based in Stockholm and the market authorization holder of Detremin,a prescription medication containing vitamin D.
Detremin is a drug content spirit vitamin D approved for the treatment of vitamin D deficiency and D-vitamin insufficiency. Detremin is the only vitamin D preparation is approved by the FDA which allows the treatment to adults, pregnant women and children with daily or weekly dosing.
For more informarion, please visit:Â www.renapharma.se
SMARTdo are an award winning producer and provider of next generation healBED vibroacoustic therapy devices, located in Northern Europe, Estonia. They are working in cooperation of Tallinn University’s Centre of Excellence in Health Promotion and Rehabilitation, also being associated member of Connected Health Cluster and The Tallinn Science Park Tehnopol. Their goal is to provide most innovative vibroacoustic therapy devices on field, being first choice to our customers.
For more information, please visit: http://www.healbed.com
In the field of applied research, Turku University of Applied Sciences represents the top tier in Finland. TUAS coordinates or acts as a partner in over 200 RDI projects yearly.
TUAS have four main fields: Culture, Business, Engineering, Social and Health Care. Engineering education is the biggest with almost 3400 students and Social and Health care is the second largest with almost 3000 students. TUAS educate experts in the fields of health care and well-being services in 15 degree programmes. Furthermore they have engineering education in eHealth technologies both in bachelor and master level.
InnopedaÂ® is a learning method developed at TUAS. It is based on experimenting, sharing know-how, and combining different approaches. With Innopeda they successfully connect teaching, research and development activities, internationality, and co-operation with working life.
Whether you are interested in updating your own skills or improving the performance of your employees, TUAS have tools for you. They offer both customized as well as ready-made training packages to suit your needs. Or if you are looking for consulting to support your education reform, you can benefit from their expertise.
For more information, please visit: https://www.tuas.fi/
The following companies/organizations are represented by following people:
|Dr. Jaanus Pikani||Documental, Estonia|
|Ms. Piia Vettik-Leemet||Tartu Biotechnology Park, Estonia|
|Mr. Jan Erik Hedborg||ApiRays|
|Mr. Priit Aigro||Smart Do, Estonia|
|Ms. Maarika Merirand||Tehnopol, Estonia|
|Dr. Pieter Spee||Fibrotx, Estonia|
|Ms. Malin Hollmark||Swedish Medtech, Sweden|
|Ms. Shampa Bari||Swecare, Sweden|
|Mr. Hakan Jideus||Predicare, Sweden|
|Mr. Pavan Asalapuram||Empe diagnostics, Sweden|
|Ms. Caroline Danielson||RenaPharma, Sweden|
|Mr. Joonas Ihalainen||iCare, Finland|
|Dr. Katja Heikkinen||Turku AMK, Finland|
|Ms. Marjatta HÃ¤sÃ¤nen||Turku AMK, Finland|
Date: 18th September 2017
Time: 6:00 PM – 8:00 PM
Venue: The Shangri-La’s Eros Hotel
Address: 19, Ashoka Rd, Janpath, Connaught Place, New Delhi, Delhi 110001
Map & directions
* Followed by cocktail and dinner